Our analysis revealed that CCL22 was expressed at low levels across all cell types, whereas TNFSF10 exhibited higher expression in cancer cells compared with other cell types in the tumor microenvironment (Supplementary Fig. S5A). This evidence concerns the gene CCL22 and cancer.